Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028
Triton’s research report infers that the North America CRISPR market is anticipated to observe growth at a CAGR of 20.28% during the forecasted years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries discussed in this market are:
• United States
• Canada
The
region’s CRISPR market is motivated by various factors, such as expanding
biopharmaceutical R&D and the presence of prominent pharma companies.
Moreover, the high health expenditure has given rise to the development of
CRISPR editing tools. Additionally, the US has the most significant number of
CRISPR publications representing comprehensive research across the region.
Hence, these factors are likely to propel the CRISPR market on a progressive
path over the upcoming years.
In
the United States, human genetic engineering has observed regulated advances.
For instance, earlier, four clinical trials used CRISPR to treat severe medical
conditions. While these are alternative therapies to CRISPR therapies, part of
gene-editing lies in the possibility of more effective treatment. There are about four ongoing clinical trials involving CRISPR that have the potential to tackle cancer such as melanoma and lymphoma, sickle cell, and even blindness. Therefore, these factors
indicate the strong growth of the CRISPR market across the United States over
the next few years.
On
the other hand, various social and ethical concerns over gene editing have
restricted the use of CRISPR technology across Canada. Moreover, the country
has implemented strict gene-editing laws. However, the gradual development in
CRISPR technology may create opportunities for the development of the CRISPR
market in the near future.
Integrated
DNA Technologies develops, manufactures, and markets nucleic acid products for
the life sciences industry. Moreover, it helps in academic research,
biotechnology, agriculture, medical diagnostics, and pharmaceutical
development. The company’s primary business includes the production of custom
oligonucleotides for molecular biology applications. Integrated DNA operates in
various countries, with headquarters in the US.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA CRISPR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON CRISPR MARKET
2.2. KEY
INSIGHTS
2.2.1. INDUSTRIAL
BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL
2.2.2. REWRITING
OF GENETIC DISORDERS THROUGH GENOME SURGERY
2.2.3. INCREASING
USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. LEGAL
& REGULATORY OUTLOOK
2.7. PATENT
OUTLOOK
2.8. FUNDING
OUTLOOK
2.9. KEY
IMPACT ANALYSIS
2.9.1. COST
2.9.2. ACCURACY
2.9.3. EASY
TO USE
2.10. KEY
MARKET STRATEGIES
2.10.1. ACQUISITIONS
2.10.2. PRODUCT
LAUNCHES
2.10.3. CONTRACTS
& PARTNERSHIPS
2.10.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.11. MARKET
DRIVERS
2.11.1. GROWING
LIFESTYLE-ORIENTED DISEASES
2.11.2. SURGING
PREVALENCE OF GENETIC DISEASES
2.12. MARKET
CHALLENGES
2.12.1. GROWING
ETHICAL ISSUES REGARDING TECHNOLOGY USE
2.12.2. LIKELY
MISUSE OF GENE-EDITING TOOL
2.13. MARKET
OPPORTUNITIES
2.13.1. ADVANCEMENTS
IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR
2.13.2. INCREASED
NEED FOR CLINICAL TRIALS
2.13.3. RISE
IN AWARENESS ABOUT GENE THERAPEUTICS
3. NORTH
AMERICA CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGNING
TOOLS
3.5. GRNA
3.6. CONTROL
KITS
3.7. LIBRARY
3.8. OTHER
PRODUCTS
4. NORTH
AMERICA CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME
EDITING/GENETIC ENGINEERING
4.2. CRISPR
PLASMID
4.3. HUMAN
STEM CELLS
4.4. GRNA
DATABASE/GENE LIBRARY
4.5. CELL
LINE ENGINEERING
5. NORTH
AMERICA CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1. THERAPEUTICS
AND DRUG DISCOVERY
5.2. BIOLOGICAL
RESEARCH
5.3. AGRICULTURAL
BIOTECH
5.4. INDUSTRIAL
BIOTECH
6. NORTH
AMERICA CRISPR MARKET – REGIONAL OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. ADDGENE
7.2. CARIBOU
BIOSCIENCES INC
7.3. CELLECTIS
BIORESEARCH SAS
7.4. CRISPR
THERAPEUTICS AG
7.5. EDITAS
MEDICINE
7.6. GENSCRIPT
7.7. HORIZON
DISCOVERY GROUP
7.8. INTEGRATED
DNA TECHNOLOGIES
7.9. INTELLIA
THERAPEUTICS
7.10. LONZA
GROUP LTD
7.11. NEW
ENGLAND BIOLABS
7.12. NOVARTIS
INTERNATIONAL AG
7.13. ORIGENE
TECHNOLOGIES INC
7.14. PRECISION
BIOSCIENCES
7.15. SYNTHEGO
CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA CRISPR
MARKET, BY COUNTRY 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: FUNDING OUTLOOK OF
PUBLIC COMPANIES
TABLE 5: FUNDING OUTLOOK OF
PRIVATE COMPANIES
TABLE 6: FUNDING OUTLOOK OF
GOVERNMENT ORGANIZATIONS
TABLE 7: NORTH AMERICA CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS
INDEX
FIGURE 2: FUNDING SCENARIO
SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 3: KEY IMPACT ANALYSIS
FIGURE 4: NORTH AMERICA CRISPR
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 5: NORTH AMERICA CRISPR
MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CRISPR
MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CRISPR
MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA CRISPR
MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CRISPR
MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA
CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA CRISPR
MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA
CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 14: NORTH AMERICA
CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA
CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA
CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA
CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA
CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA
CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: NORTH AMERICA
CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA
CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA
CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA
CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA
CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 25: UNITED STATES
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: CANADA CRISPR
MARKET 2021-2028 (IN $ MILLION)